期刊
FRONTIERS IN NEUROENDOCRINOLOGY
卷 32, 期 3, 页码 265-286出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.yfrne.2010.12.001
关键词
11 beta-Hydroxysteroid dehydrogenase; Glucocorticoids; Mineralocorticoids; HPA axis; Ageing; Anxiety; Developmental programming
资金
- Wellcome Trust [WT 079009, WT 083184]
- MRC [G0501596]
- BBSRC
- EPSRC
- ESRC
- Medical Research Council [G0501596, G0700704B] Funding Source: researchfish
- MRC [G0501596] Funding Source: UKRI
Glucocorticoids have profound effects on brain development and adult CNS function. Excess or insufficient glucocorticoids cause myriad abnormalities from development to ageing. The actions of glucocorticoids within cells are determined not only by blood steroid levels and target cell receptor density, but also by intracellular metabolism by 11 beta-hydroxysteroid dehydrogenases (11 beta-Hsp). 11 beta-HSD1 regenerates active glucocorticoids from their inactive 11-keto derivatives and is widely expressed throughout the adult CNS. Elevated hippocampal and neocortical 11 beta-HSD1 is observed with ageing and causes cognitive decline; its deficiency prevents the emergence of cognitive defects with age. Conversely, 11 beta-HSD2 is a dehydrogenase, inactivating glucocorticoids. The major central effects of 11 beta-HSD2 occur in development, as expression of 11 beta-HSD2 is high in fetal brain and placenta. Deficient feto-placental 11 beta-HSD2 results in a life-long phenotype of anxiety and cardiometabolic disorders, consistent with early life glucocorticoid programming. (C) 2010 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据